---
title: Simvastatin
description: >-
  Simvastatin is prescribed to lower cholesterol levels in the blood. It's used
  to treat several types of hyperlipidemia, including primary
  hypercholesterolemia, mixed dyslipidemia, and homozygous familial
  hypercholesterolemia. Simvastatin also reduces the risk of cardiovascular
  events like heart a...
is_banned: false
lastModified: '2025-09-22T17:21:54.140Z'
faqs:
  - q: >-
      What is the recommended dosage for Simvastatin?**


      **A:**  Adults:  Typically 10-20 mg once daily, taken in the evening, with
      a range of 5-40 mg/day. In certain situations, the maximum dose can be
      80mg if the patient has been taking this dose for at least 12 months
      without evidence of muscle toxicity. Children (10-17 years with
      heterozygous familial hypercholesterolemia): Usually 10 mg once daily,
      with a maximum dose of 40 mg/day. Dosage adjustments are needed for
      patients with severe renal impairment or drug interactions.
    a: >-
      A:**  Adults:  Typically 10-20 mg once daily, taken in the evening, with a
      range of 5-40 mg/day. In certain situations, the maximum dose can be 80mg
      if the patient has been taking this dose for at least 12 months without
      evidence of muscle toxicity. Children (10-17 years with heterozygous
      familial hypercholesterolemia): Usually 10 mg once daily, with a maximum
      dose of 40 mg/day. Dosage adjustments are needed for patients with severe
      renal impairment or drug interactions.
  - q: >-
      What are the most serious side effects of simvastatin?**


      **A:**  The most serious side effects are myopathy (muscle pain and
      weakness), which can progress to rhabdomyolysis (severe muscle breakdown),
      liver damage, and allergic reactions. Patients should be advised to
      immediately report any unexplained muscle pain or weakness, especially if
      accompanied by fever or dark urine.
    a: >-
      A:**  The most serious side effects are myopathy (muscle pain and
      weakness), which can progress to rhabdomyolysis (severe muscle breakdown),
      liver damage, and allergic reactions. Patients should be advised to
      immediately report any unexplained muscle pain or weakness, especially if
      accompanied by fever or dark urine.
  - q: >-
      What are the contraindications to using simvastatin?**


      **A:**  Simvastatin is contraindicated in patients with active liver
      disease, pregnancy, breastfeeding, hypersensitivity to simvastatin, and
      concomitant use of strong CYP3A4 inhibitors (e.g., some antifungals,
      antibiotics), gemfibrozil, cyclosporine, and danazol.
    a: >-
      A:**  Simvastatin is contraindicated in patients with active liver
      disease, pregnancy, breastfeeding, hypersensitivity to simvastatin, and
      concomitant use of strong CYP3A4 inhibitors (e.g., some antifungals,
      antibiotics), gemfibrozil, cyclosporine, and danazol.
  - q: >-
      What are the major drug interactions with simvastatin?**


      **A:**  Major drug interactions include strong CYP3A4 inhibitors (increase
      simvastatin levels and myopathy risk), other cholesterol-lowering
      medications (increased risk of myopathy), and certain heart medications
      (increase risk of myopathy). Grapefruit juice can also interact with
      simvastatin.
    a: >-
      A:**  Major drug interactions include strong CYP3A4 inhibitors (increase
      simvastatin levels and myopathy risk), other cholesterol-lowering
      medications (increased risk of myopathy), and certain heart medications
      (increase risk of myopathy). Grapefruit juice can also interact with
      simvastatin.
  - q: >-
      Can simvastatin be used during pregnancy or breastfeeding?**


      **A:**  Simvastatin is contraindicated during pregnancy and not
      recommended during breastfeeding.
    a: >-
      A:**  Simvastatin is contraindicated during pregnancy and not recommended
      during breastfeeding.
  - q: >-
      How does simvastatin work to lower cholesterol?**


      **A:**  Simvastatin inhibits HMG-CoA reductase, a key enzyme in
      cholesterol production, thus decreasing the amount of cholesterol made by
      the liver. This leads to an increase in LDL receptors, clearing more LDL
      cholesterol ("bad" cholesterol) from the bloodstream.
    a: >-
      A:**  Simvastatin inhibits HMG-CoA reductase, a key enzyme in cholesterol
      production, thus decreasing the amount of cholesterol made by the liver.
      This leads to an increase in LDL receptors, clearing more LDL cholesterol
      ("bad" cholesterol) from the bloodstream.
  - q: >-
      What should patients be monitored for while taking simvastatin?**


      **A:** Liver function tests (LFTs) and creatine kinase (CK) levels should
      be monitored periodically, particularly at the start of therapy or with
      dose increases.  Lipid profile (total cholesterol, LDL-C, HDL-C, and
      triglycerides) should also be monitored to assess treatment efficacy.
    a: >-
      A:** Liver function tests (LFTs) and creatine kinase (CK) levels should be
      monitored periodically, particularly at the start of therapy or with dose
      increases.  Lipid profile (total cholesterol, LDL-C, HDL-C, and
      triglycerides) should also be monitored to assess treatment efficacy.
  - q: >-
      What time of day should simvastatin be taken?**


      **A:** Simvastatin should be taken once daily in the evening, as
      cholesterol production is highest at night.
    a: >-
      A:** Simvastatin should be taken once daily in the evening, as cholesterol
      production is highest at night.
  - q: >-
      What are the common side effects of simvastatin?**


      **A:** Common side effects include headache, muscle aches (myalgia),
      abdominal pain, constipation, nausea, upper respiratory infections,
      diarrhea, and rash.
    a: >-
      A:** Common side effects include headache, muscle aches (myalgia),
      abdominal pain, constipation, nausea, upper respiratory infections,
      diarrhea, and rash.
  - q: >-
      .  What should a patient do if they experience muscle pain while taking
      simvastatin?**


      **A:** They should immediately report any unexplained muscle pain,
      tenderness, or weakness to their doctor, especially if accompanied by
      fever, malaise or dark urine, as this could indicate myopathy or
      rhabdomyolysis, which can be serious.
    a: >-
      A:** They should immediately report any unexplained muscle pain,
      tenderness, or weakness to their doctor, especially if accompanied by
      fever, malaise or dark urine, as this could indicate myopathy or
      rhabdomyolysis, which can be serious.
---
## **Usage**

Simvastatin is prescribed to lower cholesterol levels in the blood. It's used to treat several types of hyperlipidemia, including primary hypercholesterolemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia. Simvastatin also reduces the risk of cardiovascular events like heart attack and stroke in patients with or without existing coronary heart disease (CHD). It belongs to the pharmacological class of HMG-CoA reductase inhibitors, commonly known as statins.  Simvastatin competitively inhibits HMG-CoA reductase, a key enzyme in cholesterol biosynthesis, thus reducing cholesterol production in the liver.

## **Alternate Names**

Simvastatin is also known as simvastatin acid, particularly in its active metabolite form. Brand names for simvastatin include Zocor and FloLipid.

## **How It Works**

**Pharmacodynamics:** Simvastatin's primary effect is to lower levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C or "bad" cholesterol), and triglycerides while increasing high-density lipoprotein cholesterol (HDL-C or "good" cholesterol).  It exerts this effect primarily in the liver.

**Pharmacokinetics:**  Simvastatin is an inactive lactone prodrug that is hydrolyzed in the liver to its active beta-hydroxyacid form. Absorption following oral administration is variable, with absolute bioavailability estimated to be less than 5%. Peak plasma concentrations are reached within 1 to 2 hours. Simvastatin is extensively metabolized by the liver, primarily via CYP3A4, to various metabolites, including simvastatin acid, the principal active form. It's eliminated primarily in the feces via biliary excretion, with a small portion excreted in urine. The elimination half-life of simvastatin acid is approximately 1.9 hours.

**Mode of Action:** Simvastatin's active metabolite, simvastatin acid, competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for cholesterol biosynthesis. By inhibiting this enzyme, simvastatin reduces cholesterol production in the liver, leading to increased LDL receptor expression on hepatocytes and enhanced clearance of LDL-C from the bloodstream.  The reduction in hepatic cholesterol also decreases very-low-density lipoprotein (VLDL) production, which ultimately lowers triglycerides and may increase HDL-C.

## **Dosage**


### **Standard Dosage**

#### **Adults:**

The recommended starting dose is typically 10-20 mg once daily, taken in the evening. The dose may range from 5-40 mg daily, with a maximum dose of 80mg in specific situations. The maximum daily dose of 80 mg is recommended only in patients who have been on 80 mg chronically for 12 months or more without evidence of myopathy.

#### **Children (10-17 years with heterozygous familial hypercholesterolemia):**

The starting dose is usually 10 mg once daily, taken in the evening. The dose can be adjusted up to a maximum of 40 mg daily, according to the treatment goals and the patient's response.

#### **Special Cases:**

* **Elderly Patients:**  No specific dosage adjustment is generally necessary but close monitoring is recommended.
* **Patients with Renal Impairment:** Dosage adjustment isn't typically needed for mild to moderate impairment. For severe renal impairment, a starting dose of 5 mg daily is recommended.
* **Patients with Hepatic Dysfunction:** Simvastatin is contraindicated in patients with active liver disease or unexplained persistent elevations in liver enzymes. Caution is advised in patients with a history of liver disease or alcohol misuse.
* **Patients with Comorbid Conditions:** Close monitoring is needed for patients with conditions like diabetes, hypothyroidism, or those taking interacting medications.  Dose adjustments may be required in patients receiving concomitant cyclosporine, danazol, gemfibrozil, or strong CYP3A4 inhibitors.  Lower doses of simvastatin should be considered when combined with certain heart medications such as amiodarone, amlodipine, verapamil, or diltiazem.

### **Clinical Use Cases**

Simvastatin is not typically indicated for use in acute clinical settings like intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations. Its primary role is in long-term management of hyperlipidemia and cardiovascular risk reduction.

### **Dosage Adjustments**

Dose modifications may be necessary based on individual patient factors, including renal or hepatic dysfunction, concomitant medications, and response to therapy. Close monitoring of liver function tests and creatine kinase levels is recommended, especially during dosage titration.

## **Side Effects**


### **Common Side Effects:**

Headache, myalgia, abdominal pain, constipation, nausea, upper respiratory infection, diarrhea, and rash.

### **Rare but Serious Side Effects:**

Myopathy (muscle pain, tenderness, weakness), rhabdomyolysis (muscle breakdown), hepatitis, increased liver enzymes, and allergic reactions (including angioedema and anaphylaxis).

### **Long-Term Effects:**

Chronic complications may include increased risk of developing type 2 diabetes, cognitive impairment, and peripheral neuropathy.


### **Adverse Drug Reactions (ADR):**

Rhabdomyolysis, liver failure, and severe allergic reactions.


## **Contraindications**

* Active liver disease or unexplained persistent elevations in liver enzymes.
* Pregnancy and breastfeeding.
* Hypersensitivity to simvastatin or any component of the formulation.
* Concomitant use of strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, erythromycin, clarithromycin, HIV protease inhibitors), gemfibrozil, cyclosporine, or danazol.


## **Drug Interactions**

Simvastatin interacts with numerous medications, including:

* **Strong CYP3A4 inhibitors:**  These drugs increase simvastatin levels, significantly raising the risk of myopathy. Examples include azole antifungals (itraconazole, ketoconazole), macrolide antibiotics (erythromycin, clarithromycin), HIV protease inhibitors, and grapefruit juice.
* **Other cholesterol-lowering drugs:** Gemfibrozil, fenofibrate, and niacin may increase the risk of myopathy when combined with simvastatin.
* **Heart medications:** Amiodarone, amlodipine, verapamil, and diltiazem can increase the risk of myopathy, requiring dosage adjustments of simvastatin.
* **Immunosuppressants:** Cyclosporine increases simvastatin levels.
* **Antifungal:** Danazol increases simvastatin levels.


## **Pregnancy and Breastfeeding**

Simvastatin is contraindicated during pregnancy due to the risk of fetal harm. Cholesterol is essential for fetal development, and statins can interfere with this process. Simvastatin is not recommended during breastfeeding due to potential effects on infant lipid metabolism, although limited data are available.

## **Drug Profile Summary**

* **Mechanism of Action:** Inhibits HMG-CoA reductase, reducing cholesterol biosynthesis.
* **Side Effects:** Common: headache, myalgia, abdominal pain, constipation. Serious: myopathy, rhabdomyolysis, liver damage.
* **Contraindications:**  Active liver disease, pregnancy, breastfeeding, concomitant use of strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol.
* **Drug Interactions:** CYP3A4 inhibitors, other cholesterol-lowering drugs, certain heart medications.
* **Pregnancy & Breastfeeding:** Contraindicated in pregnancy, not recommended during breastfeeding.
* **Dosage:** Adults: 10-40 mg/day, up to 80 mg/day in specific cases. Children (10-17 years with HeFH): 10-40 mg/day.
* **Monitoring Parameters:** Liver function tests (LFTs), creatine kinase (CK) levels, lipid profile.

## **Popular Combinations**

Simvastatin is often used in combination with ezetimibe, a cholesterol absorption inhibitor, for enhanced LDL-C lowering in patients not achieving target levels with simvastatin alone.

## **Precautions**

* **General Precautions:**  Monitor liver function and CK levels. Assess for drug interactions.  Educate patients on signs and symptoms of myopathy.
* **Specific Populations:** Contraindicated during pregnancy and breastfeeding. Caution advised in patients with a history of liver disease or alcohol misuse. Dosage adjustment may be necessary in patients with severe renal impairment.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Simvastatin?**

**A:**  Adults:  Typically 10-20 mg once daily, taken in the evening, with a range of 5-40 mg/day. In certain situations, the maximum dose can be 80mg if the patient has been taking this dose for at least 12 months without evidence of muscle toxicity. Children (10-17 years with heterozygous familial hypercholesterolemia): Usually 10 mg once daily, with a maximum dose of 40 mg/day. Dosage adjustments are needed for patients with severe renal impairment or drug interactions.

### **Q2: What are the most serious side effects of simvastatin?**

**A:**  The most serious side effects are myopathy (muscle pain and weakness), which can progress to rhabdomyolysis (severe muscle breakdown), liver damage, and allergic reactions. Patients should be advised to immediately report any unexplained muscle pain or weakness, especially if accompanied by fever or dark urine.

### **Q3:  What are the contraindications to using simvastatin?**

**A:**  Simvastatin is contraindicated in patients with active liver disease, pregnancy, breastfeeding, hypersensitivity to simvastatin, and concomitant use of strong CYP3A4 inhibitors (e.g., some antifungals, antibiotics), gemfibrozil, cyclosporine, and danazol.

### **Q4: What are the major drug interactions with simvastatin?**

**A:**  Major drug interactions include strong CYP3A4 inhibitors (increase simvastatin levels and myopathy risk), other cholesterol-lowering medications (increased risk of myopathy), and certain heart medications (increase risk of myopathy). Grapefruit juice can also interact with simvastatin.

### **Q5: Can simvastatin be used during pregnancy or breastfeeding?**

**A:**  Simvastatin is contraindicated during pregnancy and not recommended during breastfeeding.

### **Q6: How does simvastatin work to lower cholesterol?**

**A:**  Simvastatin inhibits HMG-CoA reductase, a key enzyme in cholesterol production, thus decreasing the amount of cholesterol made by the liver. This leads to an increase in LDL receptors, clearing more LDL cholesterol ("bad" cholesterol) from the bloodstream.

### **Q7: What should patients be monitored for while taking simvastatin?**

**A:** Liver function tests (LFTs) and creatine kinase (CK) levels should be monitored periodically, particularly at the start of therapy or with dose increases.  Lipid profile (total cholesterol, LDL-C, HDL-C, and triglycerides) should also be monitored to assess treatment efficacy.

### **Q8: What time of day should simvastatin be taken?**

**A:** Simvastatin should be taken once daily in the evening, as cholesterol production is highest at night.


### **Q9: What are the common side effects of simvastatin?**

**A:** Common side effects include headache, muscle aches (myalgia), abdominal pain, constipation, nausea, upper respiratory infections, diarrhea, and rash.


### **Q10.  What should a patient do if they experience muscle pain while taking simvastatin?**

**A:** They should immediately report any unexplained muscle pain, tenderness, or weakness to their doctor, especially if accompanied by fever, malaise or dark urine, as this could indicate myopathy or rhabdomyolysis, which can be serious.


